Professor Dong-Woo Cho of Mechanical Engineering, Professor Jinah Jang of Creative IT Convergence Engineering, and Ms. H...
For the eighth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full en...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics in South Korea, announced an expansion of...
MEDI FUTURES, a South Korea based biomedical ultrasound company and a member company of the Born2Global Centre, sig...
South Korea headquartered Samsung BioLogics and GI Innovation have signed a Contract Development Organization ...
The precision medicine and biotechnology company Macrogen has announced on April 24 that it had signed a supply con...
Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has further strengthened its pr...
OliX Pharmaceuticals, a leading developer of RNAi therapeutics has announced that Demetrios G. Vavvas, M.D., Ph.D., one ...
GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company joins World Hemophilia D...
South Korea-based Celltrion and the Canada-based iProgen Biotech has announced to agree to partner for the de...
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, has expanded i...
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...
GCAM, Inc., headquartered in Fullerton, CA, was established in 2009 and a member of South Korea's GC grou...
LegoChem Biosciences has announced that it has entered a research collaboration and license agreement with Takeda Pharma...
PDC*line Pharma, a biotech company developing a new class of potent and scalable antigen presenting cell, based on a pro...
Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based i...
ACell, Inc. a leading regenerative medicine company, has recently announced that it has entered into an exclusive distri...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and col...
ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has announced ...
The global healthcare and medical tourism conference "Medical Korea 2019" will be held for three days from March 14 at G...
Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...
WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...
Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly ...
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...
According to reports from the Korean Herald, the government of Korea will spend 2.93 trillion won (US$2.61 billion...